Covered recipient · General Payments record
JESSICA NARVAEZ-LUGO
Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology
General Payments · PY2018–2024
$2,520.43
- Reported across 145 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $470.44 | 25 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $235.12 | 14 |
| Ardelyx, Inc. | $66.39 | 3 |
| Axonics Modulation Technologies, Inc. | $58.50 | 3 |
| GENZYME CORPORATION | $26.07 | 1 |
| Phathom Pharmaceuticals, Inc. | $25.16 | 1 |
| VIVUS LLC | $22.62 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $21.52 | 1 |
| Braintree Laboratories, Inc. | $15.06 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (25)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $9.81 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105100913 | CMS |
| ABBVIE INC. | $29.62 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105100915 | CMS |
| ABBVIE INC. | $4.93 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105100917 | CMS |
| ABBVIE INC. | $10.33 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105100919 | CMS |
| ABBVIE INC. | $17.23 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105100921 | CMS |
| ABBVIE INC. | $20.36 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105100923 | CMS |
| ABBVIE INC. | $24.55 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105100925 | CMS |
| ABBVIE INC. | $4.04 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105100927 | CMS |
| ABBVIE INC. | $16.10 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105100929 | CMS |
| ABBVIE INC. | $13.50 | 05/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105100931 | CMS |
| ABBVIE INC. | $19.72 | 06/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105100933 | CMS |
| ABBVIE INC. | $33.77 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105100935 | CMS |
| ABBVIE INC. | $26.58 | 07/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105100937 | CMS |
| ABBVIE INC. | $4.58 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105100939 | CMS |
| Ardelyx, Inc. | $21.35 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146697439 | CMS |
| Ardelyx, Inc. | $22.03 | 06/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146697441 | CMS |
| Ardelyx, Inc. | $23.01 | 07/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146697443 | CMS |
| Axonics, Inc. | $25.00 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142355815 | CMS |
| Axonics, Inc. | $13.53 | 03/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142355809 | CMS |
| Axonics, Inc. | $19.97 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142355841 | CMS |
| Braintree Laboratories, Inc. | $15.06 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125516589 | CMS |
| GENZYME CORPORATION | $26.07 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139970457 | CMS |
| Phathom Pharmaceuticals, Inc. | $25.16 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151100879 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $21.52 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153527183 | CMS |
| VIVUS LLC | $22.62 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1129417247 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.